CD2 2mg*10vials

CJC 1295 with DAC CD2 2mg*10vials

CJC 1295 is a growth hormone releasing hormone analog designed to stimulate the pituitary gland's natural growth hormone production. This version with DAC (Drug Affinity Complex) has an extended half-life, providing sustained growth hormone release over several days, representing a long-acting research peptide in endocrine and recovery studies.

The 2mg single-vial specification is the standard concentration, ideal for initial dose-response studies, extended GH pathway mechanism experiments, and researchers studying sustained growth hormone release profiles. This low-dose format offers flexibility in experimental design, allowing researchers to explore a wide range of dose levels while minimizing excessive active compound usage.

Through its targeted GHRH receptor pathway, CJC 1295 supports research into natural growth hormone release, muscle growth, fat metabolism, recovery, and sleep quality. The DAC version is designed to study the effects of continuous, elevated GH secretion patterns on physiological processes, offering a distinct research profile compared to short-acting variants.

This product is supplied as sterile lyophilized powder in glass vials, prepared for reconstitution with bacteriostatic water. Each batch undergoes rigorous purity testing, with a certificate of analysis provided.

10 vials per pack, suitable for routine laboratory research and foundational endocrine studies.